|
|
Volumn 2, Issue 4, 2005, Pages 191-197
|
|
Endothelins: pathophysiology and treatment implications in chronic heart failure.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BOSENTAN;
CYCLO(TRP ASP PRO VAL LEU);
CYCLO(TRP-ASP-PRO-VAL-LEU);
CYCLOPEPTIDE;
ENDOTHELIN;
ENDOTHELIN RECEPTOR;
SULFONAMIDE;
ANIMAL;
CONGESTIVE HEART FAILURE;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
METABOLISM;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
TREATMENT OUTCOME;
VASOCONSTRICTION;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
ENDOTHELINS;
HEART FAILURE, CONGESTIVE;
HUMANS;
PEPTIDES, CYCLIC;
RECEPTORS, ENDOTHELIN;
SULFONAMIDES;
TREATMENT OUTCOME;
VASOCONSTRICTION;
|
|
EID: 33644878609
PISSN: 15469530
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02696649 Document Type: Review |
|
Times cited : (35)
|
|
References (50)
|
